Rodzajewska, A., Kuryło, W. and Szklener, K. (2023) “Impressive clinical response following combined BRAF and MEK inhibition in a low-grade serous ovarian carcinoma patient with a BRAF V600E mutation”, Journal of Education, Health and Sport, 31(1), pp. 138–147. doi: 10.12775/JEHS.2023.31.01.012.